Tuesday, 17 November 2026European Markets

NORDIC NANOVECTOR Stock Is 9% Up So Far Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of NORDIC NANOVECTOR (Oslo Børs Benchmark Index_GI: NANOV.OL) jumped 9.32% to kr0.80 at 13:41 EST on Thursday, following the last session's downward trend. Oslo Børs Benchmark Index_GI is jumping 0.54% to kr1,249.22, after two successive sessions in a row of gains. This seems, at the moment, a somewhat up trend exchanging session today.

NORDIC NANOVECTOR's last close was kr0.73, 95.39% under its 52-week high of kr15.78.

About NORDIC NANOVECTOR

Nordic Nanovector ASA, a biopharmaceutical company, develops and commercializes therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting antibody-radionuclide-conjugate, which is in Phase 2b clinical trial for the treatment of patients with non-hodgkin lymphoma. Its preclinical development product also includes Alpha37, an anti-CD37 alphaparticle emitting radioimmunoconjugate for treating chronic lymphatic leukemia. The company has collaboration agreements with Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a treatment for patients with B-cell malignancies. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-4.09.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -155.9%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC NANOVECTOR's stock is considered to be overbought (>=80).

Moving Average

NORDIC NANOVECTOR's value is way below its 50-day moving average of kr0.98 and way below its 200-day moving average of kr2.31.

More news about NORDIC NANOVECTOR (NANOV.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 2 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›